Cancer Treatment in China for International Patients
This guide explains how cancer is treated in China, which hospitals hold national titles for cancer care, which cancer medicines are approved, and what public hospitals charge. We use Chinese government sources and the hospitals’ own statements only.
Key points- We list 26 hospitals in 22 cities. Each holds a national title for cancer care, such as the National Cancer Center or a National Clinical Key Specialty. Every title links to its source.
- China has approved 10 CAR-T products and many newer cancer medicines. Each one is approved only for certain cancers and stages.
- One IMRT radiotherapy session costs ¥1,200–1,900 at public hospitals in the four provinces we checked. Prices of medicines agreed with China’s national insurance office are not public.
- No hospital can promise a cure. Never pay to join a drug trial.
How cancer is treated in China
Chinese hospitals treat cancer with a team of doctors from different fields. This is called a multidisciplinary team (MDT). The team plans care for each patient and can use surgery, radiotherapy, chemotherapy, targeted drugs and immunotherapy. National guidelines ask for this team approach, for example the lung cancer guideline.
China has national treatment guidelines for many cancers. The 2022 set covers 21 cancer and blood diseases, as listed in the National Health Commission notice.
Doctors must follow the approved label and may use a medicine outside it only in special cases. Some targeted medicines need a gene test first. These rules are in the national guide to new cancer medicines.
Traditional Chinese medicine next to cancer care
Some cancer hospitals in China offer traditional Chinese medicine (TCM) alongside standard cancer care. TCM should not replace surgery, radiotherapy or cancer medicines when you need them. Some herbs and supplements can interact with cancer drugs, so tell your cancer team about everything you take.
How we choose these hospitals
A hospital is on this page only if it holds a national title for cancer care. These titles are the National Cancer Center and the national list of hospitals chosen to build regional cancer centres. They also include a national regional medical centre project for cancer and a National Clinical Key Specialty in oncology, thoracic surgery or haematology. For a key specialty we print the exact title the hospital uses, including “construction project”. A few hospitals are listed because their own WeChat account states their result in a national specialty ranking. We do not rank hospitals.
Hospitals for cancer care, by city
Swipe the table sideways to see all columns.
Public hospitals show their fees in their WeChat mini-program. Check the current fee there before you travel.
Cancer types
People ask about many cancer types. For each one, the table names examples of newer medicines approved in China. Each example links to the approval record of China’s drug regulator. Each medicine is approved for certain stages or after certain treatments only. Ask your doctor which one fits your case.
Swipe the table sideways to see all columns.
The titles on this page are for oncology, thoracic surgery and haematology. Thoracic surgery matches lung and oesophageal cancer, and haematology matches blood cancers. For the other types, every hospital in the city table holds a title for cancer care in general.
Lung cancer
Surgery is an important treatment for early-stage non-small cell lung cancer (NSCLC) when the tumour can be removed safely. It is also used in some stage III cases. The plan depends on the stage, the tumour’s features and the patient’s general health. Small cell lung cancer is usually treated with medicines and radiotherapy. Surgery is used only in some very early cases. Other treatments for lung cancer are radiotherapy, chemotherapy, targeted drugs and immunotherapy.
Some targeted drugs work only when the cancer has a certain gene change, such as an EGFR mutation. When a gene test is used to choose treatment, China’s guidance requires an approved test method. If you have test results from abroad, ask the hospital if they meet the rules for the medicine it suggests. Results from abroad are not always accepted, and they do not always need to be repeated.
These immunotherapy medicines (PD-1 and PD-L1 medicines) are approved in China for some lung cancers.
| Medicine | Approval source |
|---|---|
| nivolumab | NMPA approval record, 2018 |
| pembrolizumab | CDE annual review report, 2019 |
| atezolizumab | NMPA approval record, 2021 |
| durvalumab | CDE annual review report, 2019 |
| camrelizumab | NMPA approval record, 2020 |
| tislelizumab | NMPA approval record, 2021 |
| sintilimab | NMPA approval record, 2021 |
| toripalimab | NMPA approval record, 2022 |
| serplulimab | NMPA approval record, 2022 |
| ivonescimab (blocks PD-1 and VEGF) | NMPA approval record, 2024 |
Two more hospitals in Shanghai report their lung cancer surgery in their own WeChat posts.
Swipe the table sideways to see all columns.
| Hospital | City | What its own WeChat says |
|---|---|---|
| Shanghai Pulmonary Hospital 上海市肺科医院 | Shanghai | Its thoracic surgery was 2nd in the Fudan specialty reputation ranking (2021 list). (the hospital’s own WeChat post, 2022) |
| Shanghai Chest Hospital 上海市胸科医院 | Shanghai | Its thoracic surgery is a national key clinical specialty, in the hospital’s words (国家重点临床专科). (the hospital’s own WeChat post, 2026) |
Blood cancers and CAR-T
CAR-T is a treatment made from the patient’s own immune cells (T cells), changed in a lab to attack the cancer. China’s drug regulator has approved these 10 CAR-T products.
Swipe the table sideways to see all columns.
| CAR-T product | Approved for | Year | NMPA source |
|---|---|---|---|
| axicabtagene ciloleucel 阿基仑赛 | Large B-cell lymphoma | 2021 | record 1 · record 2 |
| relmacabtagene autoleucel 瑞基奥仑赛 | Large B-cell, follicular and mantle cell lymphoma | 2021 | record 1 · record 2 · record 3 |
| equecabtagene autoleucel 伊基奥仑赛 | Multiple myeloma | 2023 | record 1 · record 2 |
| inaticabtagene autoleucel 纳基奥仑赛 | Adult B-cell leukaemia; large B-cell lymphoma | 2023 | record 1 · record 2 · record 3 |
| zevorcabtagene autoleucel 泽沃基奥仑赛 | Multiple myeloma | 2024 | record 1 · record 2 |
| ciltacabtagene autoleucel 西达基奥仑赛 | Multiple myeloma | 2024 | record 1 · record 2 |
| ranicabtagene autoleucel 雷尼基奥仑赛 | Large B-cell lymphoma | 2025 | record 1 · record 2 |
| puzolcabtagene autoleucel 普基奥仑赛 | B-cell leukaemia, ages 3–21 | 2025 | record 1 · record 2 |
| satricabtagene autoleucel 舒瑞基奥仑赛 | Stomach cancer (CLDN18.2-positive) | 2026 | record 1 · record 2 |
| pocabtagene autoleucel 泊基奥仑赛 | Large B-cell lymphoma | 2026 | record 1 · record 2 |
Most of these are approved only when the cancer has come back or did not respond to earlier treatment.
Some people’s lymphoma comes back or does not respond to treatment. For some of them, national guidelines list two options: a blood stem-cell (haematopoietic) transplant or CD19 CAR-T. CD19 CAR-T targets a marker on B cells. The choice depends on the type of lymphoma, earlier treatment, the response and general health. A proven blood or bone-marrow transplant is not the same as an unproven stem-cell treatment sold as a cancer cure. See the lymphoma guideline. See also the large B-cell lymphoma guideline.
CAR-T can cause serious side effects. It needs a trained hospital team and close monitoring. Each product in the table is approved for specific uses, so the cancer name alone does not show that you can have it. Ask the hospital which case applies: an approved product used as approved, an approved product used off-label, or part of an authorised study. An offer that is not on this list is not automatically a real clinical trial. Ask for the approval, study and consent papers, and be careful with promises of a cure.
These hospitals report their results in blood cancers in their own WeChat posts.
Swipe the table sideways to see all columns.
| Hospital | City | What its own WeChat says |
|---|---|---|
| Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College 中国医学科学院血液病医院(中国医学科学院血液学研究所) | Tianjin | It has led the Fudan haematology ranking for 13 years (2021 list). (the hospital’s own WeChat post, 2022) |
| The First Affiliated Hospital of Soochow University 苏州大学附属第一医院 | Suzhou | Its haematology was 3rd in the Fudan specialty reputation ranking (2020 list). (the hospital’s own WeChat post, 2021) |
Treatments available in China
Proton and heavy-ion therapy
Proton and heavy-ion (carbon-ion) therapy are special types of radiotherapy. They suit some cancers, not all, and are not better than standard radiotherapy for every cancer. Your doctor decides. Each centre below shows its service in its own WeChat posts or in the registration of its system at China’s drug and device regulator.
Swipe the table sideways to see all columns.
| Centre | City | System | Since | Sources |
|---|---|---|---|---|
| Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine 上海交通大学医学院附属瑞金医院 | Shanghai | Proton therapy with China’s first home-made proton system, model SAPT-PS-01. NMPA registration: 2022. | In full use since November 2023 | hospital post 1 · NMPA registration |
| Shanghai Proton and Heavy Ion Center 上海市质子重离子医院 | Shanghai | Proton and carbon-ion therapy; the first hospital in China with both. More than 100 patients from abroad, its own post says. Parent hospital: Fudan University Shanghai Cancer Center. | In full operation since May 2015 | hospital post 1 |
| Wuhan Union Hospital 华中科技大学同济医学院附属协和医院 | Wuhan | Proton therapy. System: Varian ProBeam 360. NMPA registration: 2025. | In use; more than 150 patients treated by March 2026 | hospital post 1 · hospital post 2 · NMPA registration |
| The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) 中国科学技术大学附属第一医院 | Hefei | Proton therapy at its ion medical centre (Hefei Ion Medical Center). System: Varian ProBeam. | Open since April 2024 | hospital post 1 |
| Zibo Wanjie Cancer Hospital 淄博万杰肿瘤医院 | Zibo | Proton therapy; it brought in its proton system in 2001, its own post says | In clinical use since December 2004 | hospital post 1 |
| Hebei Yizhou Cancer Hospital 河北一洲肿瘤医院 | Hebei | Proton therapy at its proton medical centre; a fifth treatment room opened in August 2024 | In use (2024) | hospital post 1 |
| Gansu Wuwei Tumor Hospital 甘肃省武威肿瘤医院 | Wuwei | Carbon-ion (heavy-ion) therapy with China’s own system, model HIMM-01-GS-WW-1. NMPA registration: 2019. Its Lanzhou heavy-ion centre opened in November 2024. | Treating patients since March 2020 | hospital post 1 · hospital post 2 · NMPA registration |
Other centres in China also give proton therapy. We add more centres when we find the regulator’s registration or the hospital’s own post about the service. We do not list systems that are still in clinical trials.
What is not established care
Research is not the same as proven treatment. If a hospital offers you research, ask for the study registration, the ethics approval, the consent papers and a clear account of the risks and other options. An unapproved cell therapy is not automatically a real study. Registration also does not prove that a treatment works. China’s rules on stem-cell research are in the national stem-cell research rules.
In drug-registration trials under China’s clinical-trial rules, the sponsor must give the trial medicines free and pay for trial-related medical tests. This does not make all care or travel free. Ask for the covered and uncovered costs in writing. These duties are in the 2026 clinical-trial rules.
Be careful with research sold as a proven cure. No hospital can guarantee a cure for one patient.
Reviewed by Dr. Arif Shah, MBBS · 2026-11-16.
Cost of cancer care in China
These are government prices for public tertiary (grade 3) hospitals in Beijing, Shanghai, Guangdong and Tianjin, from documents in force in 2024–2026. Beijing and Guangdong set maximum prices. Guangdong’s radiotherapy prices are Guangzhou’s. The median is the middle price of the four provinces.
Swipe the table sideways to see all columns.
| Item | Median | Range | Provinces |
|---|---|---|---|
| Drip (infusion), per drip — chemotherapy is given this way | ¥12 | ¥5–¥18 | 4 |
| 3D conformal radiotherapy, per session | ¥1,125 | ¥850–¥1,310 | 4 |
| IMRT (intensity-modulated radiotherapy), per session | ¥1,745 | ¥1,200–¥1,900 | 4 |
| CT (computed tomography) scan with contrast, per body part | ¥297.5 | ¥203–¥305 | 4 |
| MRI (magnetic resonance imaging) with contrast, per body part | ¥550 | ¥455–¥555 | 4 |
| PET-CT (positron emission tomography with CT), whole body | ¥5,000 | same in all 4 | 4 |
| Needle biopsy (chest) | ¥112 | ¥65–¥177 | 4 |
| Pathology diagnosis | ¥137.5 | ¥110–¥150 | 4 |
| Immunohistochemistry, per slide | ¥185 | ¥150–¥252 | 4 |
| Hospital bed, 3-bed room, per day | ¥68.5 | ¥64–¥70 | 4 |
Medicines, tests and other services are charged on top. Prices of medicines agreed with China’s national insurance office are not public. Check the current fee in the hospital’s WeChat mini-program.
Examples: what a course of care can cost
These examples multiply the government prices above by a course length from China’s national treatment guidelines. They show hospital service charges only. They are illustrations, not a standard course and not your bill. Your doctors decide your tests and treatment.
First tests before treatment. This is an illustration: CT with contrast of 2 body parts, a needle biopsy, a pathology diagnosis and 4 immunohistochemistry slides. It is not a checklist; your doctors decide which tests you need and how many. A whole-body PET-CT, if your doctor asks for one, adds ¥5,000.
Radiotherapy to the whole breast after surgery, short course. This is an illustration: 15 sessions of IMRT, one of the schedules in the national breast cancer guideline. Your doctors choose the schedule and technique. The total includes the one-off fees for simulation, planning and plan verification, from one plan (lower figure) up to the limit the price documents allow (higher figure).
Radiotherapy to the whole breast after surgery, standard course. This is an illustration: 25 sessions of IMRT, one of the schedules in the national breast cancer guideline. Your doctors choose the schedule and technique. The total includes the one-off fees for simulation, planning and plan verification, from one plan (lower figure) up to the limit the price documents allow (higher figure).
Chemotherapy after lung cancer surgery. The national lung cancer guideline recommends 4 cycles of platinum-based chemotherapy after surgery for stage II–III non-small cell lung cancer. We show no total, because the length of each cycle, the number of drips and any hospital stay depend on the medicines your doctors choose. Ask the hospital for a written estimate.
Swipe the table sideways to see all columns.
| Example | Median | Beijing | Shanghai | Guangdong | Tianjin |
|---|---|---|---|---|---|
| First tests before treatment | ¥1,547 | ¥1,256 | ¥1,664 | ¥1,945 | ¥1,430 |
| Breast radiotherapy, 15 sessions | ¥29,936–32,408 | ¥34,740–39,080 | ¥26,704–27,328 | ¥33,168–37,488 | ¥21,625–24,150 |
| Breast radiotherapy, 25 sessions | ¥47,386–49,858 | ¥53,740–58,080 | ¥43,504–44,128 | ¥51,268–55,588 | ¥33,625–36,150 |
One-off radiotherapy fees. Each price document limits how often these fees may be charged in one course. In Beijing, the document allows planning up to 2 times per course, and verification no more often than planning. In Shanghai, the document allows simulation, planning and verification up to 2 times each per course. In Guangdong, the document allows planning up to 2 times per course (Guangzhou prices). In Tianjin, the document allows planning and verification up to 2 times per course, for a plan in one body area. Being allowed to charge a fee twice does not mean you will need it twice.
Planning your treatment trip
- Prepare your records. Collect your doctor’s reports, your pathology and gene-test results, and your scans (the reports and the image files).
- Choose a hospital and contact it. Use the city table above. To see which hospitals list an international department, use our table of international patient services.
- Get your visa. China has no special medical visa. Most patients use an S2 visa with an invitation letter from the hospital (our visa guide is linked below this page). Some nationalities can enter without a visa.
- Plan how long you stay. It depends on the treatment and your plan. For CAR-T, national guidance describes living near the hospital for about four weeks after treatment; the exact rule depends on the product. Ask the hospital for its plan.
- Plan how to pay. Hospitals usually ask for a deposit before a stay (our guide to paying at hospitals is linked below this page). Some insurers pay the hospital for you: see direct billing by insurer.
- Get language help. Our guide to medical interpreters is linked below this page.
- Going home. Before you leave, ask the hospital for copies of your reports and your discharge summary, so your doctor at home can go on with your care.
Often searched by international patients
| Hospital | City |
|---|---|
| Modern Cancer Hospital Guangzhou 广州现代医院 also known as Modern Hospital Guangzhou | Guangzhou |
Frequently asked questions
Which hospital is best for cancer treatment in China?
We do not rank hospitals. The city table on this page lists hospitals with national titles for cancer care. Choose by your cancer type, the city and whether the hospital has an international department.
How much does cancer treatment cost in China?
It depends on the cancer, the plan and the city. We checked public hospitals in four provinces.
One IMRT radiotherapy session: RMB 1,200–1,900.
A whole-body PET-CT scan: RMB 5,000.
Ask the hospital for a written estimate before you travel.
Is cancer treatment free for foreigners in China?
No, foreign patients usually pay for their own care. China’s national medical insurance covers people who are insured in China. Foreign patients pay the hospital themselves or use their own insurance. Some insurers pay the hospital directly.
How do I come to China for cancer treatment? Is there a medical visa?
China has no special medical visa. Most patients use an S2 visa with an invitation letter from the hospital. Some nationalities can enter without a visa. The section on planning your treatment trip shows each step.
Can a family member stay with the patient in hospital?
Each hospital sets its own rules, and they change. For example, one cancer hospital in Tianjin lets one family member stay with a pass from the nurses’ desk, as stated in its 2019 notice. Ask the ward about the current rule when the patient is admitted.
Can hospitals in China treat stage 4 cancer?
Yes, hospitals in China treat stage 4 cancer. Treatment can control the cancer, ease symptoms and help you live as well as possible. The plan depends on the cancer type, where it has spread and your general health. China’s lung cancer guideline includes palliative radiotherapy and chemotherapy. Palliative care can start early, alongside cancer treatment. No hospital can promise a cure, so ask the team what they expect in your case.
Did China find a cure for cancer?
No single treatment cures every kind of cancer. Some cancers can be cured, especially when they are found early. For other cancers, treatment aims to control the disease and ease symptoms. China has approved new medicines, such as CAR-T for some blood cancers and for one stomach cancer (CLDN18.2-positive). They help only some patients. Ask your doctor what is realistic for your cancer.
Is CAR-T safe? What are the side effects?
CAR-T can cause serious side effects. These include cytokine release syndrome (fever, low blood pressure and breathing problems) and nervous-system problems. A trained hospital team gives CAR-T and follows you closely. Monitoring rules differ by product. The 2024 Chinese guide describes at least 10 days of monitoring in a trained facility and four weeks living nearby after axicabtagene ciloleucel treatment. It describes daily nervous-system checks for 14 days and four weeks living nearby after zevorcabtagene autoleucel treatment. Ask the hospital for the plan for your product.
Which hospitals in China offer proton or carbon-ion therapy?
Seven hospitals in China offer proton therapy, carbon-ion therapy or both. Two are in Shanghai, and one each is in Wuhan, Hefei, Zibo (Shandong), Zhuozhou (Hebei) and Wuwei (Gansu). Carbon-ion therapy is offered in Shanghai and in Wuwei, whose heavy-ion centre in Lanzhou opened in 2024. The proton and heavy-ion table on this page links each hospital’s own post and, where found, its NMPA device registration. Ask the centre whether your cancer type and stage suit this treatment.
Which cancers can CAR-T treat in China?
CAR-T products are approved in China for some patients with large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, B-cell leukaemia, multiple myeloma or CLDN18.2-positive stomach cancer. Most are used after the cancer comes back or does not respond to earlier treatment. Some have narrower limits. For example, the stomach cancer product is for HER2-negative tumours after at least two earlier treatments. Ask the hospital which approved product fits your case.
Can traditional Chinese medicine cure cancer?
No, traditional Chinese medicine (TCM) is not a proven cure for cancer on its own. It should not replace standard cancer treatment. Tell your cancer team about every TCM product, herb and supplement you use, because some can interact with cancer medicines.
Can foreigners join clinical trials in China?
It depends on the trial. Before you travel, ask the study team if you meet its rules and if consent, communication and follow-up can be arranged. In drug-registration trials under China’s rules, the sponsor must give the trial medicines free and pay for trial-related medical tests. Other care and travel are not free, so ask for all costs in writing.
How do I check a cancer hospital in China?
Check its national titles on this page, its hospital grade and its licence. Our guide explains how Chinese hospitals are classified.
Medical answers reviewed by Dr. Arif Shah, MBBS · 2026-11-16.
Get help choosing a hospital
Tell us your diagnosis and recent test results. Our care team will suggest suitable hospitals from this list, explain the likely costs, and can arrange a medical interpreter in 48 Chinese cities.
WhatsApp and Telegram: +86 135 2232 3808. You can also use the live chat on this site at any time. We guide and arrange; treatment decisions stay with you and your doctors.